US Executive Compensation Proxy SEC Filings — July 30, 2026

30-07-2026

Mexco Energy Corporation filed a DEF 14A proxy statement for its Annual Meeting of Stockholders to be held on September 8, 2026. The meeting will include the election of five director nominees, ratification of Weaver & Tidwell, L.L.P. as independent auditor, approval of the Amended and Restated 2019 Employee Incentive Stock Plan, and a non-binding advisory vote on executive compensation. The filing notes that director Michael J. Banschbach did not stand for reelection, while the board recommends a vote 'For' all proposals.

• · The record date for voting is July 20, 2026, with 2,046,000 shares of common stock outstanding.
• · Director Michael J. Banschbach did not stand for reelection at this year's Annual Meeting.
• · The board has determined that four outside directors (Messrs. Banschbach, Clayton, Decker, and Schroeder) are independent under NYSE American rules.
• · Proxy solicitation will commence on or about August 3, 2026.
• · Stockholders may obtain the Annual Report on Form 10-K free of charge from the SEC website or the company website.

30-07-2026

Zoned Properties, Inc. is seeking stockholder approval at a Special Meeting on September 11, 2026, for the sale of substantially all of its assets to BPB Partners, LLC, a company owned by its Chairman/CEO/CFO Bryan McLaren, President/COO Berekk Blackwell, and employee Patrick Moroney (the Management Group). The Asset Sale, valued at $8.5 million in cash plus the assumption of approximately $5.0 million in liabilities, will result in the company exiting its cannabis real estate operations. While the Board recommends the sale, citing a fairness opinion from Marshall & Stevens, the transaction involves significant conflicts of interest as the buyer is controlled by senior management, and the company's future as a public entity pursuing a merger is uncertain.

• · The Asset Sale is a related-party transaction as BPB Partners is owned by the company's top executives.
• · The company does not intend to liquidate after the sale and is exploring a merger with another operating company, but no assurance of completion.
• · The Special Meeting will be held virtually on September 11, 2026, with record date of July 15, 2026.
• · Stockholders are also asked to vote on an advisory (non-binding) proposal regarding executive compensation related to the Asset Sale.
• · No dissenters' rights are available for stockholders opposing the Asset Sale.

30-07-2026

Lamb Weston Holdings, Inc. filed its DEF 14A proxy statement for the 2026 Annual Meeting of Shareholders, scheduled for September 16, 2026. The meeting includes four proposals: election of directors, an advisory vote on executive compensation, approval of the 2026 Equity and Incentive Compensation Plan (authorizing up to 5,000,000 new shares), and ratification of KPMG LLP as independent auditors. The proxy highlights a refreshed board with several new directors, including Scott Ostfeld from JANA Partners, and outlines the company's executive compensation program designed to link pay to performance.

• · The 2026 Plan will replace the 2016 Plan, which expires on November 9, 2026.
• · The record date for the annual meeting is July 24, 2026.
• · The meeting will be held at Lamb Weston's headquarters in Eagle, Idaho.
• · The board includes several new directors appointed in 2025 and 2026, reflecting a significant refresh.
• · Scott Ostfeld, Managing Partner at JANA Partners, joined the board in 2025 and serves on the Nominating and Corporate Governance Committee.

30-07-2026

30-07-2026

Daily Journal Corp filed a DEF 14A proxy statement on July 30, 2026, which includes a detailed appendix on dissenters' rights under South Carolina law. The filing outlines procedures for shareholders to dissent from certain corporate actions and obtain fair value for their shares. No specific financial results, corporate actions, or performance metrics are disclosed in this filing.

• · The proxy statement includes a full reproduction of South Carolina Code of Laws Title 33, Chapter 13 on dissenters' rights.
• · Shareholders may dissent from mergers, share exchanges, asset sales, charter amendments, and conversions into LLCs or partnerships.
• · Dissenters' rights are not available for shares listed on a national securities exchange or designated as a national market system security.
• · The filing does not propose any specific corporate action triggering dissenters' rights.

30-07-2026

Ocugen, Inc. is holding a Special Meeting of Stockholders on September 21, 2026 to vote on increasing authorized common shares by 250,000,000 (from 390,000,000 to 640,000,000) and on an adjournment proposal. The company highlights recent milestones including paying off high-interest debt, a partnership with Roots Pharmaceutical for OCU400 in the Middle East and North Africa, and advancing Phase 3 discussions for OCU410. However, the share increase will cause dilution for existing stockholders, and the company acknowledges reliance on equity financing despite efforts to pursue alternative capital sources.

• · The company completed a private offering of $130.0M in 6.75% convertible senior notes due 2034 in May 2026.
• · Under the indenture for the notes, Ocugen must obtain stockholder approval for the share increase or a reverse stock split by September 30, 2026 to cover shares issuable upon conversion.
• · The company plans three BLA submissions by 2028.
• · The Special Meeting will be virtual only, with no physical location.
• · The Board unanimously recommends voting FOR both proposals.